Detalhe da pesquisa
1.
Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.
J Allergy Clin Immunol
; 132(1): 45-54, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23591272
2.
An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
J Med Econ
; 26(1): 189-199, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36691763
3.
Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After Implantation.
Clin Ther
; 45(2): 136-150, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746736
4.
Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy: systematic review and meta-analysis.
J Neurol
; 269(6): 2874-2891, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034187
5.
Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation vs. responsive neurostimulation or deep brain stimulation for the treatment of drug-resistant epilepsy: analyses of a large United States healthcare claims database.
J Med Econ
; 25(1): 1218-1230, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36384429
6.
Variation in access to specialist services for neurosurgical procedures in adults with epilepsy in England, a cohort study.
Seizure
; 2022 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36646536
7.
An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
J Med Econ
; 24(1): 1037-1051, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348576
8.
Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
Adv Ther
; 35(10): 1686-1696, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30143957
9.
Correction to: Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
Adv Ther
; 35(10): 1697, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30209749